COMMON STOCK

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

COMMON STOCK

6.     COMMON STOCK

At March 31, 2023, the Company's authorized capital stock was 150,000,000 shares of common stock, par value $0.001 per share, and 25,000,000 shares of preferred stock, par value $0.001 per share. On that date, the Company had 52,768,382 shares of common stock issued and 52,264,932 shares of common stock outstanding, and no shares of preferred stock outstanding.

Stock-based compensation expense related to Company grants for the three months ended March 31, 2023 was $618,244. Stock-based compensation expense for the three months ended March 31, 2022 was $569,502.

2023 Transactions: During the three months ended March 31, 2023 the Company issued 118,000 shares of common stock for vested stock awards and no exercise of stock options. During the three months ended March 31, 2023 the Company repurchased 200,000 shares of its common stock at a cost of $666,018 or $3.33 per share. The Company also granted 270,000 restricted stock awards during the three months ended March 31, 2023.

2022 Transactions: During the three months ended March 31, 2022 the Company issued 123,000 shares of common stock for vested stock awards. The Company also granted 100,000 restricted stock awards during the three months ended March 31, 2022.